Report reviews new drugs’ potential impact on future drug spending in Canada

The Patented Medicine Prices Review Board has released an extensive listing of new medicines in the late stages of clinical evaluation that it predicts may “significantly impact clinical practice or drug...

Already a subscriber? Click here to view full article